Cue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Rhea-AI Summary

Cue Health (NASDAQ: HLTH), a leader in healthcare technology, announced its participation in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022. Cue Health provides individuals with easy access to health information and diagnostics, enabling effective health management. The company is recognized for its FDA-authorized at-home COVID-19 test and has received various international approvals, including CE mark in the EU and authorization from Health Canada and India. Founded in 2010, Cue is headquartered in San Diego.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the 7^th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 16, 2022.

About Cue Health
Cue is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore's Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005096/en/

Lorna Williams ir@cuehealth.com

Cue Health press@cuehealth.com

Source: Cue Health Inc.

FAQ

What is Cue Health's participation in the Needham Virtual Med Tech Conference?

Cue Health (NASDAQ: HLTH) will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.

What is special about Cue Health's COVID-19 test?

Cue Health's COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home use without a prescription.

What international approvals has Cue Health received?

Cue Health has received the CE mark in the EU, Interim Order authorization from Health Canada, and regulatory approval from India's Central Drugs Standard Control Organization.

When was Cue Health founded?

Cue Health was founded in 2010.

Where is Cue Health headquartered?

Cue Health is headquartered in San Diego.